Recent analyst reports show shifts in ratings for Bicycle Therapeutics, Pilgrim's Pride, NantHealth, and Provident Financial. Plus, a look at quantum computing stocks. Read more...

Recent analyst actions have stirred the tech stock market, with upgrades and downgrades impacting companies like Viridian Therapeutics, Denali, GigaCloud, Intellia, Micron, and VEON. Read more...

Analyst downgrades and insider selling have sent several stocks tumbling, including Adient, Foot Locker, and ProPetro. Meanwhile, Walmart is drawing attention for positive management changes. Read more...

A roundup of recent business news, including North Carolina's export success, Amalgamated Bank's REIT investment, and analyst ratings for various stocks like Grupo Aeroportuario del Pacífico and Maravai LifeSciences. Read more...

A roundup of stock analysis reports, comparing companies in the energy and finance sectors, including DraftKings, FTC Solar, and more. Read more...

Recent analyst downgrades have impacted the stock prices of several companies listed on the NYSE, including AES, Dell Technologies, GE Vernova, and Cava Group. This article provides an overview of these changes and their potential implications. Read more...

A look at the latest business news, including Rigel Pharmaceuticals' earnings call, Unifi's cost-cutting plans, Analog Devices' buy rating, and Visa/Mastercard investment opportunities. Read more...

Recent analyst actions affect the stock outlook for Scotts Miracle-Gro (SMG), Titan America (TTAM), and Chipotle Mexican Grill (CMG). Get the latest ratings and target prices. Read more...

Cantor Fitzgerald has issued "strong-buy" ratings for multiple stocks, including Immunovant, Ardelyx, Kura Oncology, and Mesoblast. Meanwhile, Bank of America adjusts price targets for Gilead Sciences and Immunovant. Read more...

Oracle enjoys a record-breaking year with a UK sales milestone and reaffirmed "buy" ratings from analysts. Plus, insights into Warren Buffett's investment strategy. Read more...